Paul Black is CEO at ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX). They have made 24 open-market trades across 1 company since 2012, most recently 2024-07-05.
CIK 0001511354
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $1.8M since 2012, against 17 sales. Across 7 scored buys the stock is down 3.0% at ninety days, and 5.1 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 14% | 14% |
| Avg Move | -9.0% | -1.8% | -3.0% |
| Alpha | -2.0% | -0.3% | -5.1% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDRX | SELL | 2022-06-10 | 2022-06-13 | $16.58 | $2.0M | -0.1% | -7.4% | +9.5% |
| MDRX | SELL | 2022-06-06 | 2022-06-07 | $17.32 | $3.6M | -13.6% | -15.4% | -3.5% |
| MDRX | SELL | 2022-06-03 | 2022-06-06 | $17.33 | $2.6M | -14.3% | -13.5% | -3.1% |
| MDRX | SELL | 2022-05-17 | 2022-05-19 | $18.18 | $909K | +1.2% | -10.1% | +3.6% |
| MDRX | SELL | 2022-05-13 | 2022-05-16 | $18.01 | $1.8M | -5.2% | -11.7% | -2.2% |
| MDRX | SELL | 2022-03-10 | 2022-03-10 | $21.87 | $1.3M | +1.1% | +1.2% | -21.7% |
| MDRX | SELL | 2021-12-10 | 2021-12-10 | $17.68 | $1.1M | +4.8% | +0.7% | +24.8% |
| MDRX | SELL | 2021-09-09 | 2021-09-10 | $14.52 | $871K | -4.1% | -3.7% | +22.3% |
| MDRX | SELL | 2021-06-14 | 2021-06-14 | $17.66 | $2.1M | +6.2% | +2.5% | -18.0% |
| MDRX | SELL | 2021-03-15 | 2021-03-15 | $15.72 | $943K | -3.4% | -0.1% | +12.2% |
| MDRX | SELL | 2020-12-14 | 2020-12-16 | $14.03 | $842K | +4.1% | +21.4% | +12.1% |
| MDRX | SELL | 2020-10-14 | 2020-10-16 | $11.04 | $331K | -9.5% | +14.9% | +52.7% |
| MDRX | BUY | 2020-03-05 | 2020-03-05 | $7.47 | $505K | -30.5% | -7.9% | -7.3% |
| MDRX | BUY | 2018-12-12 | 2018-12-13 | $10.10 | $500K | -9.9% | +12.8% | +4.0% |
| MDRX | SELL | 2017-12-14 | 2017-12-18 | $14.35 | $215K | -2.7% | +2.3% | -13.9% |
| MDRX | SELL | 2017-09-14 | 2017-09-18 | $13.52 | $203K | +3.0% | +0.7% | +7.8% |
| MDRX | SELL | 2016-09-15 | 2016-09-16 | $13.00 | $195K | +1.0% | -0.2% | -18.5% |
| MDRX | SELL | 2016-06-13 | 2016-06-15 | $13.04 | $196K | -4.3% | +12.2% | +2.8% |
| MDRX | SELL | 2016-03-30 | 2016-04-01 | $13.31 | $200K | +0.4% | -0.6% | -6.6% |
| MDRX | BUY | 2014-12-12 | 2014-12-15 | $11.51 | $75K | -4.5% | -3.5% | -3.5% |
| MDRX | BUY | 2014-11-11 | 2014-11-12 | $11.26 | $250K | -4.5% | -3.5% | -3.5% |
| MDRX | BUY | 2013-05-15 | 2013-05-16 | $14.02 | $100K | -4.5% | -3.5% | -3.5% |
| MDRX | BUY | 2013-03-12 | 2013-03-13 | $12.69 | $300K | -4.5% | -3.5% | -3.5% |
| MDRX | BUY | 2012-06-07 | 2012-06-11 | $10.94 | $100K | -4.5% | -3.5% | -3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.